637 related articles for article (PubMed ID: 19706683)
1. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
[TBL] [Abstract][Full Text] [Related]
2. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
5. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.
Kano MR; Morishita Y; Iwata C; Iwasaka S; Watabe T; Ouchi Y; Miyazono K; Miyazawa K
J Cell Sci; 2005 Aug; 118(Pt 16):3759-68. PubMed ID: 16105884
[TBL] [Abstract][Full Text] [Related]
6. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
7. Involvement of signaling of VEGF and TGF-beta in differentiation of sinusoidal endothelial cells during culture of fetal rat liver cells.
Yoshida M; Nishikawa Y; Omori Y; Yoshioka T; Tokairin T; McCourt P; Enomoto K
Cell Tissue Res; 2007 Aug; 329(2):273-82. PubMed ID: 17450384
[TBL] [Abstract][Full Text] [Related]
8. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
9. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
Reynolds AR; Reynolds LE; Nagel TE; Lively JC; Robinson SD; Hicklin DJ; Bodary SC; Hodivala-Dilke KM
Cancer Res; 2004 Dec; 64(23):8643-50. PubMed ID: 15574772
[TBL] [Abstract][Full Text] [Related]
10. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
Chai J; Jones MK; Tarnawski AS
FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species.
Michaud SE; Dussault S; Groleau J; Haddad P; Rivard A
J Mol Cell Cardiol; 2006 Aug; 41(2):275-84. PubMed ID: 16806264
[TBL] [Abstract][Full Text] [Related]
12. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
Dardik R; Inbal A
Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line.
Fukushima K; Miyamoto S; Tsukimori K; Kobayashi H; Seki H; Takeda S; Kensuke E; Ohtani K; Shibuya M; Nakano H
Biol Reprod; 2005 Jul; 73(1):172-9. PubMed ID: 15788755
[TBL] [Abstract][Full Text] [Related]
14. Cooperative signaling for angiogenesis and neovascularization by VEGF and HGF following islet transplantation.
Golocheikine A; Tiriveedhi V; Angaswamy N; Benshoff N; Sabarinathan R; Mohanakumar T
Transplantation; 2010 Oct; 90(7):725-31. PubMed ID: 20714284
[TBL] [Abstract][Full Text] [Related]
15. Involvement of gamma-secretase in postnatal angiogenesis.
Hayashi H; Nakagami H; Takami Y; Sato N; Saito Y; Nishikawa T; Mori M; Koriyama H; Tamai K; Morishita R; Kaneda Y
Biochem Biophys Res Commun; 2007 Nov; 363(3):584-90. PubMed ID: 17888873
[TBL] [Abstract][Full Text] [Related]
16. 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires STAT3-dependent expression of VEGF.
Srivastava K; Kundumani-Sridharan V; Zhang B; Bajpai AK; Rao GN
Cancer Res; 2007 May; 67(9):4328-36. PubMed ID: 17483346
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
18. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
[TBL] [Abstract][Full Text] [Related]
19. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
Mallet C; Vittet D; Feige JJ; Bailly S
Stem Cells; 2006 Nov; 24(11):2420-7. PubMed ID: 17071858
[TBL] [Abstract][Full Text] [Related]
20. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]